Literature DB >> 22214528

Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes.

Yared Tekabe1, Xiaoping Shen, Joane Luma, Drew Weisenberger, Shi Fang Yan, Roland Haubner, Ann Marie Schmidt, Lynne Johnson.   

Abstract

BACKGROUND: Receptor for advanced glycation endproducts (RAGE) expression contributes to the impaired angiogenic response to limb ischemia in diabetes. The aim of this study was to detect the effect of increased expression of RAGE on the angiogenic response to limb ischemia in diabetes by targeting αvβ3 integrin with 99mTc-labeled Arg-Gly-Asp (RGD).
METHODS: Male wild-type (WT) C57BL/6 mice were either made diabetic or left as control for 2 months when they underwent femoral artery ligation. Four groups were studied at days 3 to 7 after ligation: WT without diabetes (NDM) (n = 14), WT with diabetes (DM) (n = 14), RAGE-/- NDM (n = 16), and RAGE-/- DM (n = 14). Mice were injected with 99mTc-HYNIC-RGD and imaged. Count ratios for ischemic/non-ischemic limbs were measured. Muscle was stained for RAGE, αvβ3, and lectins.
RESULTS: There was no difference in count ratio between RAGE-/- and WT NDM groups. Mean count ratio was lower for WT DM (1.38 ± 0.26) vs. WT NDM (1.91 ± 0.34) (P<0.001). Mean count ratio was lower for the RAGE-/- DM group than for RAGE-/- NDM group (1.75 ± 0.22 vs. 2.02 ± 0.29) (P<0.001) and higher than for the WT DM group (P<0.001). Immunohistopathology supported the scan findings.
CONCLUSIONS: In vivo imaging of αvβ3 integrin can detect the effect of RAGE on the angiogenic response to limb ischemia in diabetes.

Entities:  

Year:  2011        PMID: 22214528      PMCID: PMC3192466          DOI: 10.1186/2191-219X-1-3

Source DB:  PubMed          Journal:  EJNMMI Res            Impact factor:   3.138


  22 in total

1.  RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins.

Authors:  K J Bayless; R Salazar; G E Davis
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Regenerative medicine in the treatment of peripheral arterial disease.

Authors:  Erica B Sneider; Philip T Nowicki; Louis M Messina
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

3.  Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.

Authors:  Vadim Tchaikovski; Servé Olieslagers; Frank-D Böhmer; Johannes Waltenberger
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

4.  Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia.

Authors:  Jing Hua; Lawrence W Dobrucki; Mehran M Sadeghi; Jiasheng Zhang; Brian N Bourke; Patti Cavaliere; James Song; Conroy Chow; Neda Jahanshad; Niels van Royen; Ivo Buschmann; Joseph A Madri; Marivi Mendizabal; Albert J Sinusas
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

5.  Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.

Authors:  Oren M Tepper; Robert D Galiano; Jennifer M Capla; Christoph Kalka; Paul J Gagne; Glen R Jacobowitz; Jamie P Levine; Geoffrey C Gurtner
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

6.  [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.

Authors:  Clemens Decristoforo; Bluma Faintuch-Linkowski; Ana Rey; Elisabeth von Guggenberg; Marco Rupprich; Ignacio Hernandez-Gonzales; Teodoro Rodrigo; Roland Haubner
Journal:  Nucl Med Biol       Date:  2006-11       Impact factor: 2.408

7.  Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.

Authors:  David F Meoli; Mehran M Sadeghi; Svetlana Krassilnikova; Brian N Bourke; Frank J Giordano; Donald P Dione; Haili Su; D Scott Edwards; Shuang Liu; Thomas D Harris; Joseph A Madri; Barry L Zaret; Albert J Sinusas
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.

Authors:  D R Senger; S R Ledbetter; K P Claffey; A Papadopoulos-Sergiou; C A Peruzzi; M Detmar
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

9.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

Authors:  Cindy J M Loomans; Eelco J P de Koning; Frank J T Staal; Maarten B Rookmaaker; Caroline Verseyden; Hetty C de Boer; Marianne C Verhaar; Branko Braam; Ton J Rabelink; Anton-Jan van Zonneveld
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

10.  Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium.

Authors:  Lynne L Johnson; Lorraine Schofield; Tammy Donahay; Mark Bouchard; Athena Poppas; Roland Haubner
Journal:  JACC Cardiovasc Imaging       Date:  2008-07
View more
  6 in total

1.  Imaging VEGF Receptors and αvβ3 Integrins in a Mouse Hindlimb Ischemia Model of Peripheral Arterial Disease.

Authors:  Yared Tekabe; Qing Li; Geping Zhang; Jordan Johnson; Ann Marie Schmidt; Marina Backer; Joseph Backer; Lynne L Johnson
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

2.  The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice.

Authors:  Laura M Hansen; Divya Gupta; Giji Joseph; Daiana Weiss; W Robert Taylor
Journal:  Lab Invest       Date:  2016-11-21       Impact factor: 5.662

3.  Single-photon emission computed tomography/computed tomography imaging of RAGE in smoking-induced lung injury.

Authors:  Monica P Goldklang; Yared Tekabe; Tina Zelonina; Jordis Trischler; Rui Xiao; Kyle Stearns; Krissy Rodriguez; Alexander Shields; Alexander Romanov; Jeanine M D'Armiento; Lynne L Johnson
Journal:  Respir Res       Date:  2019-06-10

4.  Novel Receptor for Advanced Glycation End Products-Blocking Antibody to Treat Diabetic Peripheral Artery Disease.

Authors:  Lynne L Johnson; Jordan Johnson; Rebecca Ober; April Holland; Geping Zhang; Marina Backer; Joseph Backer; Ziad Ali; Yared Tekabe
Journal:  J Am Heart Assoc       Date:  2020-12-17       Impact factor: 5.501

5.  Imaging receptor for advanced glycation end product expression in mouse model of hind limb ischemia.

Authors:  Yared Tekabe; Maria Kollaros; Chong Li; Geping Zhang; Ann Marie Schmidt; Lynne Johnson
Journal:  EJNMMI Res       Date:  2013-05-11       Impact factor: 3.138

6.  VEGF receptor targeted imaging of angiogenic response to limb ischemia in diabetic vs. non-diabetic Yucatan minipigs.

Authors:  Lynne L Johnson; Jordan Johnson; Ziad Ali; Yared Tekabe; Rebecca Ober; Gail Geist; Alicia McLuckie; Aram Safarov; April Holland; Geping Zhang; Marina Backer; Joseph Backer
Journal:  EJNMMI Res       Date:  2020-05-12       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.